| 000 | 01525 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517224509.0 | ||
| 264 | 0 | _c20190930 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1557-8615 | ||
| 024 | 7 |
_a10.1016/j.jcrc.2018.05.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRussell, James A | |
| 245 | 0 | 0 |
_aDays alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials. _h[electronic resource] |
| 260 |
_bJournal of critical care _c10 2018 |
||
| 300 |
_a333-337 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDobutamine _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine _xtherapeutic use |
| 650 | 0 | 4 |
_aEpinephrine _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeurophysins _xmetabolism |
| 650 | 0 | 4 |
_aNorepinephrine _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Precursors _xmetabolism |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aShock _xmortality |
| 650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aVasopressins _xmetabolism |
| 700 | 1 | _aLee, Terry | |
| 700 | 1 | _aSinger, Joel | |
| 700 | 1 | _aDe Backer, Daniel | |
| 700 | 1 | _aAnnane, Djillali | |
| 773 | 0 |
_tJournal of critical care _gvol. 47 _gp. 333-337 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcrc.2018.05.003 _zAvailable from publisher's website |
| 999 |
_c28585262 _d28585262 |
||